<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>NUTRILYTE II- potassium acetate, sodium chloride, sodium acetate, magnesium chloride and calcium chloride injection, solution, concentrate </strong><br>American Regent, Inc.<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1><span class="Bold">NUTRILYTE II (Multi-Electrolyte Concentrate)</span></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_77bfc67f-bf3e-44aa-859e-538111737fc7"></a><a name="section-1"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">Rx Only</span></p>
<p><span class="Bold">Not for direct infusion. For prescription compounding of intravenous admixtures only. Concentrated solution. Dilute to appropriate strength with suitable intravenous fluid prior to administration.</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="LINK_d5dcd49d-6ebd-4573-97c8-361681172dcc"></a><a name="section-2"></a><p></p>
<h1><span class="Bold">DESCRIPTION</span></h1>
<p class="First">Nutrilyte II (Multi-Electrolyte Concentrate) is a sterile, nonpyrogenic, concentrated solution of intra- and extracellular electrolytes, excluding phosphate. No antimicrobial agent has been added.</p>
<p>It is available in a 20 mL single dose preparation and a 100 mL Pharmacy Bulk Package.</p>
<p>The 100 mL Pharmacy Bulk Package contains many doses for use in a pharmacy admixture program in the preparation of parenteral fluids. See directions for dispensing from the 100 mL Pharmacy Bulk Package.</p>
<table>
<col>
<col>
<col>
<tbody class="Headless">
<tr class="First">
<td valign="top"> Electrolytes (mEq):</td>
<td align="center" valign="top"> per mL</td>
<td align="center" valign="top"> Per 20 mL</td>
</tr>
<tr>
<td valign="top"> Acetate</td>
<td align="center" valign="top"> 1.475</td>
<td align="center" valign="top"> 29.5</td>
</tr>
<tr>
<td valign="top"> Potassium</td>
<td align="center" valign="top"> 1</td>
<td align="center" valign="top"> 20</td>
</tr>
<tr>
<td valign="top"> Chloride</td>
<td align="center" valign="top"> 1.75</td>
<td align="center" valign="top"> 35</td>
</tr>
<tr>
<td valign="top"> Sodium</td>
<td align="center" valign="top"> 1.75</td>
<td align="center" valign="top"> 35</td>
</tr>
<tr>
<td valign="top"> Magnesium</td>
<td align="center" valign="top"> 0.25</td>
<td align="center" valign="top"> 5</td>
</tr>
<tr>
<td valign="top"> Calcium</td>
<td align="center" valign="top"> 0.225</td>
<td align="center" valign="top"> 4.5</td>
</tr>
<tr><td align="center" colspan="3" valign="top"> </td></tr>
<tr>
<td valign="top"> Nutrilyte II contains:</td>
<td align="center" valign="top"> per mL</td>
<td align="center" valign="top"> per 20 mL</td>
</tr>
<tr>
<td valign="top"> Potassium Acetate, USP</td>
<td align="center" valign="top"> 98 mg</td>
<td align="center" valign="top"> 1.96 grams</td>
</tr>
<tr>
<td valign="top"> Sodium Chloride, USP</td>
<td align="center" valign="top"> 74.5 mg</td>
<td align="center" valign="top"> 1.49 grams</td>
</tr>
<tr>
<td valign="top"> Sodium Acetate 3H<span class="Sub">2</span>O, USP</td>
<td align="center" valign="top"> 64.6 mg</td>
<td align="center" valign="top"> 1.292 grams</td>
</tr>
<tr>
<td valign="top"> Magnesium Chloride 6H<span class="Sub">2</span>O, USP</td>
<td align="center" valign="top"> 25.5 mg</td>
<td align="center" valign="top"> 0.51 gram</td>
</tr>
<tr>
<td valign="top"> Calcium Chloride 2H<span class="Sub">2</span>O, USP</td>
<td align="center" valign="top"> 16.55 mg</td>
<td align="center" valign="top"> 0.331 gram</td>
</tr>
<tr>
<td valign="top"> Water for Injection, USP</td>
<td align="center" valign="top"> q.s.</td>
<td align="center" valign="top"> q.s.</td>
</tr>
<tr class="Last"><td colspan="3" valign="top"> pH (6.3 to 7.0) adjusted with Glacial Acetic Acid when necessary.</td></tr>
</tbody>
</table>
<p><span class="Bold">Calculated Osmolarity:</span>Approximately 6212 mOsmol/Liter; 6.2 mOsmol/mL.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="LINK_f0c707e6-d161-41f4-80ff-0f1298464ce9"></a><a name="section-3"></a><p></p>
<h1><span class="Bold">CLINICAL PHARMACOLOGY</span></h1>
<p class="First">Nutrilyte II Concentrate provides a source of intra- and extracellular electrolytes in suitable amounts, to help maintain normal cellular metabolism during total parenteral nutrition (TPN) and other parenteral therapy in adults. Use of properly diluted Nutrilyte II meets most adult daily electrolyte requirements and provides adjunctive therapy for replenishment of depleted electrolyte stores.</p>
<p><span class="Bold"><span class="Italics">Intracellular</span></span><span class="Bold">:</span>Potassium, the principal intracellular cation, maintains the integrity of the cellular membrane, helps transport dextrose across the cell membrane and contributes to normal renal function: Magnesium, the second most concentrated intracellular cation, acts as an important cofactor in enzymatic reactions and helps to maintain normal central nervous system activity and amino acid utilization. Calcium participates in the maintenance of normal neuromuscular functions and blood coagulation.</p>
<p><span class="Bold"><span class="Italics">Extracellular</span></span><span class="Bold">:</span>Chloride, the primary extracellular anion, contributes to the maintenance of acid-base balance. Sodium, the principal extracellular cation, acts in conjunction with potassium to maintain integrity of the cell membrane. Sodium also helps to maintain motor nerve depolarization, normal renal metabolism and fluid balance. Acetate is a <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> alternate and an important intermediate in the tricarboxylic acid cycle.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="LINK_5b1fc6a6-c174-453f-b95e-4cb201861ec5"></a><a name="section-4"></a><p></p>
<h1><span class="Bold">INDICATIONS AND USAGE</span></h1>
<p class="First">Nutrilyte II Concentrate is indicated for use as a supplement to parenteral nutritional solutions containing amino acids, dextrose and/or other calorie sources delivered by central venous or peripheral infusion to facilitate amino acid utilization and maintain electrolyte balance in adults.</p>
<p>Nutrilyte II Concentrate is also indicated as a source of replacement electrolytes for the depleted adult patient during parenteral therapy.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="LINK_9c687e88-adbd-4f1b-aeef-fdbe58fb6b63"></a><a name="section-5"></a><p></p>
<h1><span class="Bold">CONTRAINDICATIONS</span></h1>
<p class="First">Nutrilyte II Concentrate is contraindicated in clinical conditions where additives of potassium, sodium, calcium, magnesium or chloride could be clinically detrimental. Such conditions include <span class="product-label-link" type="condition" conceptid="4090272" conceptname="Anuria">anuria</span>, <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span>, <span class="product-label-link" type="condition" conceptid="316135" conceptname="Atrioventricular block">heart block</span> or myocardial damage and <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span> due to cardiovascular, renal or <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">hepatic failure</span>.</p>
<p><span class="Bold">Nutrilyte II Concentrate is not intended for pediatric use.</span></p>
<p>Use only if solution is clear and seal intact.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="LINK_d373471e-067a-437f-96c7-7b5248e1129b"></a><a name="section-6"></a><p></p>
<h1><span class="Bold">WARNINGS</span></h1>
<ol class="Arabic">
<li><span class="Bold">Strongly hypertonic solutions. Must be properly diluted and thoroughly mixed before injection.</span></li>
<li>
<span class="Bold">Contains no phosphate.</span>Patients receiving TPN solutions containing concentrated dextrose may also require phosphate in addition to Nutrilyte II. It is necessary to take into consideration the calcium and magnesium ions in this solution in order to avoid precipitation where phosphate is present in the diluted solution. Phosphate (10-15 mEq/L), calcium (5 mEq/L) and magnesium (5-10 mEq/L) rarely are incompatible when properly mixed. Higher levels must be added cautiously with adequate mixing (avoid layering) and inspection. Additional calcium and phosphate may be added to alternate bottles. If additional phosphate is required, it is essential to consider the salt form because of pre-existing levels of potassium and the final concentration of phosphate in the infusate. 

</li>
<li>Each 20 mL of Nutrilyte II contains 20 mEq of potassium. Patient requirements should be carefully evaluated prior to the addition of any potassium salt to a solution containing Nutrilyte II. 

</li>
<li>This product contains aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum.<br><br>Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration.</li>
</ol>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="LINK_b55a1f58-eed0-4bae-9c4f-e9e3e6f9677f"></a><a name="section-7"></a><p></p>
<h1><span class="Bold">PRECAUTIONS</span></h1>
<ol class="Arabic">
<li>To minimize the risk of possible incompatibilities arising from mixing this solution with other additives that may be prescribed, the final infusate should be inspected for cloudiness or precipitation immediately after mixing, prior to administration and periodically during administration.</li>
<li>Blood levels of sodium, potassium, calcium, magnesium, phosphorus and chloride should be monitored frequently during parenteral nutrition or intravenous therapy, and the daily dosage of electrolytes may require tailoring to meet individual needs. In tissue <span class="product-label-link" type="condition" conceptid="4077438" conceptname="Electrolyte depletion">electrolyte depletion</span>, addition of certain electrolytes may be required to meet individual patient needs.</li>
<li>Care must be exercised administering solutions containing up to 30 mEq of sodium and 40 mEq of potassium per liter to patients with renal or cardiovascular insufficiency, particularly if they are postoperative or elderly. Sodium-containing solutions should be administered with caution to patients receiving corticosteroids or corticotropin or to other salt-retaining patients. Potassium replacement therapy may be guided by serial electrocardiograms since plasma levels are not necessarily indicative of tissue potassium levels.</li>
<li>Administration of barbiturates, narcotics or hypnotics should be adjusted with caution in patients also receiving magnesium-containing solutions because of an additive central depressive effect.</li>
<li>Parenteral magnesium and/or calcium and/or potassium should be administered with extreme caution to patients receiving digitalis preparations.</li>
<li>Extraordinary electrolyte and <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">fluid losses</span> are not necessarily corrected by infusion of solutions containing Nutrilyte II. In order to avoid deficits, special consideration must be given to replacement of excessive fluid and electrolyte losses in such conditions as protracted <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> or <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, nasogastric suction or <span class="product-label-link" type="condition" conceptid="4043006" conceptname="Fistula">fistula</span> drainage.</li>
<li>If both phosphate and a Nutrilyte II Concentrate are to be added to the solution for TPN administration, add the Nutrilyte Il Concentrate to one container (either to the amino acids or the concentrated dextrose) and add the phosphate to the other to avoid physical incompatibilities between calcium and phosphorus.</li>
</ol>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="LINK_e0417290-aab1-4e11-ae45-34b31b8023ed"></a><a name="section-8"></a><p></p>
<h1><span class="Bold">ADVERSE REACTIONS</span></h1>
<p class="First">Symptoms may result from an excess or deficit of one or more of the ions present in Nutrilyte II Multi- Electrolyte Concentrate. Therefore, frequent monitoring of blood electrolyte levels is essential.</p>
<p>Sodium excess can cause <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span> and subsequent <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span> in patients with cardiovascular insufficiency.</p>
<p>Potassium excess can cause an abnormal electrocardiogram, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span> leading to <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">cardiac arrest</span>, <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paresthesias</span> and <span class="product-label-link" type="condition" conceptid="4193951" conceptname="Flaccid paralysis">flaccid paralysis</span>, <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">mental confusion</span> and <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>.</p>
<p>Potassium deficit can impair neuromuscular function and cause <span class="product-label-link" type="condition" conceptid="4311399" conceptname="Dilatation of intestine">intestinal dilatation</span> and <span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">ileus</span>.</p>
<p>Magnesium excess can cause <span class="product-label-link" type="condition" conceptid="79908" conceptname="Muscle weakness">muscular weakness</span>, <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>, <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">circulatory collapse</span> and <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> of cardiac and central nervous system function. <span class="product-label-link" type="condition" conceptid="4029273" conceptname="Magnesium deficiency">Magnesium deficiency</span> can cause hyperirritability <span class="product-label-link" type="condition" conceptid="436073" conceptname="Psychotic disorder">psychotic</span> behavior, <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span> and neuromuscular dysfunction.</p>
<p>Calcium excess can cause <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headaches</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, <span class="product-label-link" type="condition" conceptid="4011527" conceptname="Spatial disorientation">disorientation</span>, <span class="product-label-link" type="condition" conceptid="135360" conceptname="Syncope">syncope</span>, <span class="product-label-link" type="condition" conceptid="31317" conceptname="Dysphagia">dysphagia</span>, <span class="product-label-link" type="condition" conceptid="4002033" conceptname="Muscle relaxation">hypotonia</span> of skeletal and smooth muscles, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span> and <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span>. Calcium deficits can produce neuromuscular <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">hyperexcitability</span> (<span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paresthesias</span>, <span class="product-label-link" type="condition" conceptid="75635" conceptname="Cramp">cramps</span>, <span class="product-label-link" type="condition" conceptid="380534" conceptname="Tetany">tetany</span> and <span class="product-label-link" type="condition" conceptid="374924" conceptname="Generalized convulsive epilepsy">grand mal seizures</span>).</p>
<p>Phosphorus deficiency may lead to impaired tissue oxygenation and <span class="product-label-link" type="condition" conceptid="435503" conceptname="Hemolytic anemia">acute hemolytic anemia</span>. Relative to calcium, excessive phosphorus intake can precipitate <span class="product-label-link" type="condition" conceptid="435510" conceptname="Hypocalcemia">hypocalcemia</span> with ensuing neuromuscular <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">hyperexcitability</span>.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="LINK_aa1ed483-ab64-4a6e-ac1b-bf14eb6dcd86"></a><a name="section-9"></a><p></p>
<h1><span class="Bold">DOSAGE AND ADMINISTRATION</span></h1>
<p class="First">For adults, one 20 mL dose of Nutrilyte II should be added to each liter of amino acid/dextrose solution (TPN) or other suitable intravenous solution.</p>
<p><span class="Bold"><span class="Italics">Route</span></span><span class="Bold">: </span>Nutrilyte II Concentrate is for prescription compounding of intravenous admixtures only. The solution is strongly hypertonic. Not for direct patient injection. Dilute to appropriate strength with suitable intravenous fluid prior to administration.</p>
<p><span class="Bold">DIRECTIONS FOR DISPENSING FROM 100 mL PHARMACY BULK PACKAGE—NOT FOR DIRECT INFUSION</span></p>
<p>The 100 mL Pharmacy Bulk Package is for use in a Pharmacy Admixture Service only. The 100 mL Pharmacy Bulk Package should be suspended (inverted) by its IV hang label in a laminar flow hood or biological safety cabinet. Prior to entering a Pharmacy Bulk Package remove the flip-off seal and cleanse the rubber closure with a suitable antiseptic agent. Entry into the Pharmacy Bulk Package must be made with a sterile transfer set or other sterile dispensing device and the contents dispensed in aliquots using aseptic technique. Use of a syringe needle is not recommended as it may cause leakage. ANY UNUSED PORTION MUST BE DISCARDED WITHIN 4 HOURS AFTER INITIAL ENTRY. The date and the time initially opened should be recorded in the space provided on the Pharmacy Bulk Package label.</p>
<p>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="LINK_5b0fee25-e1f9-45a7-b10f-3dbafcd0371f"></a><a name="section-10"></a><p></p>
<h1><span class="Bold">HOW SUPPLIED</span></h1>
<p class="First">Nutrilyte II (Multi-Electrolyte Concentrate)</p>
<p>NDC 0517-2020-25 20 mL Single Dose Vial Boxes of 25</p>
<p>For preparing 1 Liter TPN Solution.</p>
<p>NDC 0517-2000-25 100 mL Pharmacy Bulk Package Boxes of 25</p>
<p>Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30° C (59° to 86°F) (See USP Controlled Room Temperature).</p>
<p><span class="Bold">AMERICAN</span><span class="Bold"><br></span><span class="Bold">REGENT, INC.</span><span class="Bold"><br></span><span class="Bold">SHIRLEY, NY 11967</span></p>
<p>IN2000<br>Rev. 1/09</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="LINK_906bebae-035d-4e1e-aebe-5e1929c84748"></a><a name="section-11"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 20 mL</h1>
<p class="First"><span class="Bold">NDC 0517-2020-25</span></p>
<p><span class="Bold">NUTRILYTE II</span><span class="Bold"><span class="Sup">®</span></span><br>(Multi-Electrolyte Concentrate)</p>
<p><span class="Bold">Electrolytes (mEq/20 mL):<br>Acetate 29.5, <br>Potassium 20,<br>Chloride 35, Sodium 35,<br>Magnesium 5, Calcium 4.5</span></p>
<p><span class="Bold">20 mL</span> SINGLE DOSE VIAL</p>
<p>FOR IV USE AFTER DILUTION</p>
<p><span class="Bold">Rx Only</span></p>
<p><span class="Bold">AMERICAN REGENT, INC.</span><br>SHIRLEY, NY 11967</p>
<div class="Figure"><img alt="Container" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=18b660e8-a70b-4393-b1f3-c4aa3f8597aa&amp;name=nutrilyte-ii-1.jpg"></div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="LINK_a81ef553-6356-4e20-aaf8-851aa80ec622"></a><a name="section-12"></a><p></p>
<h1>PRINICIPAL DISPLAY PANEL - 100 mL</h1>
<p class="First"><span class="Bold"><span class="Underline">Container</span></span></p>
<p><span class="Bold">NDC 0517-2000-25</span></p>
<p><span class="Bold">NUTRILYTE II<span class="Sup">® </span></span>(Multi-Electrolyte Concentrate)</p>
<p><span class="Bold">100 mL PHARMACY BULK PACKAGE<br>NOT FOR DIRECT INFUSION</span></p>
<p>FOR IV USE AFTER DILUTION</p>
<p><span class="Bold">Rx Only</span></p>
<p>Each mL provides:<br>Electrolytes (mEq): Acetate 1.475, <br>Potassium 1, Chloride 1.75, <br>Sodium 1.75, Magnesium 0.25, <br>Calcium 0.225<br><br><img alt="Container" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=18b660e8-a70b-4393-b1f3-c4aa3f8597aa&amp;name=nutrilyte-ii-2.jpg"><br><br><br><span class="Bold"><span class="Underline">Carton<br><br></span>NDC 0517-2000-25</span></p>
<p><span class="Bold">NUTRILYTE II6212 mOsmol/Liter</span><br>(Multi-Electrolyte Concentrate)</p>
<p><span class="Bold">100 mL PHARMACY BULK PACKAGE<br>NOT FOR DIRECT INFUSION</span></p>
<p>FOR IV USE AFTER DILUTION</p>
<p><span class="Bold">Rx Only</span></p>
<p>Each mL provides:<span class="Bold"><br>Electrolytes (mEq): Acetate 1.475, Potassium 1, Chloride 1.75, <br>Sodium 1.75, Magnesium 0.25, Calcium 0.225</span><br><br><img alt="Carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=18b660e8-a70b-4393-b1f3-c4aa3f8597aa&amp;name=nutrilyte-ii-3.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>NUTRILYTE II 		
					</strong><br><span class="contentTableReg">multi-electrolyte injection, solution, concentrate</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0517-2020</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>POTASSIUM ACETATE</strong> (POTASSIUM CATION) </td>
<td class="formItem">POTASSIUM ACETATE</td>
<td class="formItem">98 mg  in 1 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>SODIUM CHLORIDE</strong> (CHLORIDE ION) </td>
<td class="formItem">SODIUM CHLORIDE</td>
<td class="formItem">74.5 mg  in 1 mL</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>SODIUM ACETATE</strong> (ACETATE ION) </td>
<td class="formItem">SODIUM ACETATE ANHYDROUS</td>
<td class="formItem">64.6 mg  in 1 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>MAGNESIUM CHLORIDE</strong> (MAGNESIUM CATION) </td>
<td class="formItem">MAGNESIUM CHLORIDE</td>
<td class="formItem">25.5 mg  in 1 mL</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>CALCIUM CHLORIDE</strong> (CALCIUM CATION) </td>
<td class="formItem">CALCIUM CHLORIDE</td>
<td class="formItem">16.55 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ACETIC ACID</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0517-2020-25</td>
<td class="formItem">25  in 1 TRAY</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">20 mL in 1 VIAL, SINGLE-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">UNAPPROVED DRUG OTHER</td>
<td class="formItem"></td>
<td class="formItem">10/01/1990</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>NUTRILYTE II 		
					</strong><br><span class="contentTableReg">multi-electrolyte injection, solution, concentrate</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0517-2000</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>POTASSIUM ACETATE</strong> (POTASSIUM CATION) </td>
<td class="formItem">POTASSIUM ACETATE</td>
<td class="formItem">98 mg  in 1 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>SODIUM CHLORIDE</strong> (CHLORIDE ION) </td>
<td class="formItem">SODIUM CHLORIDE</td>
<td class="formItem">74.5 mg  in 1 mL</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>SODIUM ACETATE</strong> (ACETATE ION) </td>
<td class="formItem">SODIUM ACETATE</td>
<td class="formItem">64.6 mg  in 1 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>MAGNESIUM CHLORIDE</strong> (MAGNESIUM CATION) </td>
<td class="formItem">MAGNESIUM CHLORIDE</td>
<td class="formItem">25.5 mg  in 1 mL</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>CALCIUM CHLORIDE</strong> (CALCIUM CATION) </td>
<td class="formItem">CALCIUM CHLORIDE</td>
<td class="formItem">16.55 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ACETIC ACID</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0517-2000-25</td>
<td class="formItem">25  in 1 TRAY</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">100 mL in 1 VIAL, PHARMACY BULK PACKAGE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">UNAPPROVED DRUG OTHER</td>
<td class="formItem"></td>
<td class="formItem">10/01/1990</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>American Regent, Inc.
							(622781813)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Luitpold Pharmaceuticals, Inc.</td>
<td class="formItem"></td>
<td class="formItem">002033710</td>
<td class="formItem">ANALYSIS(0517-2020, 0517-2000), MANUFACTURE(0517-2020, 0517-2000), STERILIZE(0517-2020, 0517-2000)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 9/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>9548eb0b-412e-4ded-b441-f36cd9a50a87</div>
<div>Set id: 18b660e8-a70b-4393-b1f3-c4aa3f8597aa</div>
<div>Version: 2</div>
<div>Effective Time: 20140902</div>
</div>
</div> <div class="DistributorName">American Regent, Inc.</div></p>
</body></html>
